ELIZA CHAKRABORTY: Difference between revisions
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
| title=Eliza Chakraborty – Prof Biotechnology and Biomedical Scientist | | title=Eliza Chakraborty – Prof Biotechnology and Biomedical Scientist | ||
| title_mode=append | | title_mode=append | ||
| keywords=Eliza Chakraborty, Eliza Chakraborty Prof Biotechnology, Eliza Chakraborty Biomedical Scientist, Eliza Chakraborty CDRI Lucknow, Eliza Chakraborty Geffen School of Medicine UCLA, Eliza Chakraborty Stemformatic India, Eliza Chakraborty DST-FIST Centre, Eliza Chakraborty Meerut Institute of Engineering and Technology, Eliza Chakraborty Bharat Gaurav Puraskar | | keywords=Eliza Chakraborty, Eliza Chakraborty Prof Biotechnology, Eliza Chakraborty Biomedical Scientist, Eliza Chakraborty CDRI Lucknow, Eliza Chakraborty Geffen School of Medicine UCLA, Eliza Chakraborty Stemformatic India, Eliza Chakraborty DST-FIST Centre, Eliza Chakraborty Meerut Institute of Engineering and Technology, Eliza Chakraborty Bharat Gaurav Puraskar, Eliza Chakraborty Self Employed, Eliza Chakraborty Biosafety, Eliza Chakraborty Technology Transfer | ||
| description=Eliza Chakraborty is a Prof Biotechnology and Biomedical Scientist with 27 years of experience, including 10 years in the USA, known for her work in stem cell technology | | description=Eliza Chakraborty is a Prof Biotechnology and Biomedical Scientist with 27 years of experience, including 10 years in the USA, known for her work in stem cell technology, biomedical research, and biosafety training, based in India. | ||
| image=Eliza Chakraborty.jpeg | | image=Eliza Chakraborty.jpeg | ||
| image_alt=Eliza Chakraborty profile image | | image_alt=Eliza Chakraborty profile image | ||
| Line 9: | Line 9: | ||
{{FeaturedSnippet | {{FeaturedSnippet | ||
| snippet1=Eliza Chakraborty is a professor of biotechnology and biomedical scientist with 27 years of experience, including 10 years in the USA, known for her research in stem cell technology and biomedical sciences. | | snippet1=Eliza Chakraborty is a professor of biotechnology and biomedical scientist with 27 years of experience, including 10 years in the USA, known for her research in stem cell technology and biomedical sciences. | ||
| snippet2=Who is Eliza Chakraborty? Eliza Chakraborty is a professor of biotechnology and biomedical scientist with a PhD from CDRI Lucknow and postdoctoral experience in the USA and India. She has held faculty positions including at the Geffen School of Medicine, UCLA, | | snippet2=Who is Eliza Chakraborty? Eliza Chakraborty is a professor of biotechnology and biomedical scientist with a PhD from CDRI Lucknow and postdoctoral experience in the USA and India. She has held faculty positions including at the Geffen School of Medicine, UCLA, and at Meerut Institute of Engineering and Technology (2014–2025), and has received the Best Educationist Award and Bharat Gaurav Puraskar. She is currently self-employed. | ||
| snippet3=Eliza Chakraborty Contact? | | snippet3=Eliza Chakraborty Contact? Eliza Chakraborty can be reached at profeliza.64@gmail.com. | ||
| keywords=Eliza Chakraborty, Eliza Chakraborty Prof Biotechnology, Eliza Chakraborty Biomedical Scientist, Eliza Chakraborty CDRI Lucknow, Eliza Chakraborty Geffen School of Medicine UCLA, Eliza Chakraborty Stemformatic India, Eliza Chakraborty DST-FIST Centre, Eliza Chakraborty Meerut Institute of Engineering and Technology, Eliza Chakraborty Bharat Gaurav Puraskar | | keywords=Eliza Chakraborty, Eliza Chakraborty Prof Biotechnology, Eliza Chakraborty Biomedical Scientist, Eliza Chakraborty CDRI Lucknow, Eliza Chakraborty Geffen School of Medicine UCLA, Eliza Chakraborty Stemformatic India, Eliza Chakraborty DST-FIST Centre, Eliza Chakraborty Meerut Institute of Engineering and Technology, Eliza Chakraborty Bharat Gaurav Puraskar, Eliza Chakraborty Self Employed, Eliza Chakraborty Biosafety, Eliza Chakraborty Technology Transfer | ||
}} | }} | ||
{{infow | {{infow | ||
| Line 21: | Line 21: | ||
| occupation = Prof Biotechnology and Biomedical Scientist | | occupation = Prof Biotechnology and Biomedical Scientist | ||
| education = PhD (CDRI, Lucknow, India), Post Doc (USA and India) | | education = PhD (CDRI, Lucknow, India), Post Doc (USA and India) | ||
| employer = Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh | | employer = Self-employed (formerly Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, 2014–2025) | ||
| position = Professor of Biotechnology & HOD, DST-FIST Center | | position = Formerly Professor of Biotechnology & HOD, DST-FIST Center, Meerut Institute of Engineering and Technology | ||
| knownfor = Stem cell technology, Biomaterials & Tissue engineering, Cancer Stem cell targeted drug discovery | | knownfor = Stem cell technology, Biomaterials & Tissue engineering, Cancer Stem cell targeted drug discovery | ||
| yearsactive = 27 years (including 10 years in the USA) | | yearsactive = 27 years (including 10 years in the USA) | ||
| role = Founder and Head of DST-FIST Centre, Medical Translational Biotechnology Lab and Stem cell & cancer cell culture lab | | role = Founder and Head of DST-FIST Centre, Medical Translational Biotechnology Lab and Stem cell & cancer cell culture lab | ||
| awards = Best Educationist Award (KTK Outstanding Achievers and Education Foundation, 2022), Bharat Gaurav Puraskar (KTK Outstanding Achievers and Education Foundation, 2022) | | awards = Best Educationist Award (KTK Outstanding Achievers and Education Foundation, 2022), Bharat Gaurav Puraskar (KTK Outstanding Achievers and Education Foundation, 2022) | ||
| email = profeliza.64@gmail.com | |||
}} | }} | ||
Eliza Chakraborty is an Indian professor of biotechnology and biomedical scientist known for her extensive research in stem cell technology, biomaterials, tissue engineering, and cancer stem cell targeted drug discovery. She has 27 years of experience, including 10 years in the USA, and has contributed significantly to biomedical sciences | Eliza Chakraborty is an Indian professor of biotechnology and biomedical scientist known for her extensive research in stem cell technology, biomaterials, tissue engineering, and cancer stem cell targeted drug discovery. She has 27 years of experience, including 10 years in the USA, and has contributed significantly to biomedical sciences. She served as Professor of Biotechnology and Head of the DST-FIST Center at Meerut Institute of Engineering and Technology (MIET), Meerut, Uttar Pradesh, from 2014 to 2025, and is currently self-employed. | ||
==Education== | ==Education== | ||
| Line 34: | Line 35: | ||
==Career== | ==Career== | ||
Eliza Chakraborty has served as faculty at the Geffen School of Medicine, University of California, Los Angeles (UCLA). She was the Head of the DST-FIST Centre from 2019 to 2024 and has been a professor of biotechnology from 2013 to 2025, with 27 years of overall professional experience, including 10 years in the USA. | Eliza Chakraborty has served as faculty at the Geffen School of Medicine, University of California, Los Angeles (UCLA). She was the Head of the DST-FIST Centre from 2019 to 2024 and has been a professor of biotechnology from 2013 to 2025, with 27 years of overall professional experience, including 10 years in the USA. From 2014 to 2025, she served as Professor of Biotechnology and Head of Department (HOD), DST-FIST Center, at Meerut Institute of Engineering and Technology (MIET), Meerut, Uttar Pradesh, and was the founder and head of the DST-FIST Centre, Medical Translational Biotechnology Lab, and Stem cell & cancer cell culture lab there. She is currently self-employed. | ||
She introduced Stemformatic in India in 2016 at the Science Congress. She also pioneered the introduction of Biosafety Level 2 laboratories in semi-urban areas of India. Her research areas include stem cell technology, biomaterials and tissue engineering, cancer stem cell targeted drug discovery, alternative native animal model development, and infectious diseases. Her infectious disease research has been sponsored by WHO, ICMR India, and NIH USA. | She introduced Stemformatic in India in 2016 at the Science Congress. She also pioneered the introduction of Biosafety Level 2 laboratories in semi-urban areas of India. Her research areas include stem cell technology, biomaterials and tissue engineering, cancer stem cell targeted drug discovery, alternative native animal model development, and infectious diseases. Her infectious disease research has been sponsored by WHO, ICMR India, and NIH USA. | ||
| Line 40: | Line 41: | ||
Eliza Chakraborty has overseen outcomes-based student projects and provided senior student mentorship. | Eliza Chakraborty has overseen outcomes-based student projects and provided senior student mentorship. | ||
She holds four granted patents and has eight patents | She holds four granted patents and has eight patents pending. | ||
She is a life member of the Indian Science Congress and the Indian Academy of Biomedical Science (IABS). She served as an executive board member of IABS from 2019 to 2024 and was a national advisory board member of IABS from 2020 to 2022. | She is a life member of the Indian Science Congress and the Indian Academy of Biomedical Science (IABS). She served as an executive board member of IABS from 2019 to 2024 and was a national advisory board member of IABS from 2020 to 2022. | ||
Her first review article, on hydrogel-based tissue engineering, has surpassed 100 citations. The article was written in collaboration with her student and later research collaborator, Shikha, and focused on biomaterials, a widely relevant subject in the field, at a time when Shikha was transitioning her career toward an M.Tech. | Her first review article, on hydrogel-based tissue engineering, has surpassed 100 citations. The article was written in collaboration with her student and later research collaborator, Shikha, and focused on biomaterials, a widely relevant subject in the field, at a time when Shikha was transitioning her career toward an M.Tech. | ||
For more than five years, Eliza Chakraborty has served as a Biosafety Resource Person, including for DBT Star College, and has trained more than 1,000 young aspirants in Biosecurity (Biosafety and Lab Safety). | |||
==Achievements== | ==Achievements== | ||
| Line 52: | Line 55: | ||
* Bharat Gaurav Puraskar – conferred by the KTK Outstanding Achievers and Education Foundation on 24 July 2022, in New Delhi, in recognition of her outstanding achievements and contribution in the field of Biomedical Sciences. | * Bharat Gaurav Puraskar – conferred by the KTK Outstanding Achievers and Education Foundation on 24 July 2022, in New Delhi, in recognition of her outstanding achievements and contribution in the field of Biomedical Sciences. | ||
* Author of "Hydrogel based tissue engineering and its future applications in personalized disease modeling and regenerative therapy," published in the Beni-Suef University Journal of Basic and Applied Sciences (Springer Nature), which has surpassed 100 citations. | * Author of "Hydrogel based tissue engineering and its future applications in personalized disease modeling and regenerative therapy," published in the Beni-Suef University Journal of Basic and Applied Sciences (Springer Nature), which has surpassed 100 citations. | ||
* Overseen outcomes-based student projects | |||
* Holds 4 granted patents, with 8 patents pending | |||
* Author of a recent research paper that has received 110 citations, published in a Scientific journal with an impact factor above 20 | |||
* Trained more than 1,000 young aspirants in Biosecurity (Biosafety and Lab Safety) | |||
* Served for more than 5 years as a Biosafety Resource Person, including for DBT Star College | |||
==Technology Transfer Readiness== | |||
Eliza Chakraborty has indicated readiness for technology transfer on the following developments: | |||
* Cost-effective Biomaterials for 3D cell culture and Bioink | |||
* Early and stage-dependent biomarker-based prostate cancer detection product, ready to launch | |||
* Cost-effective stem cell isolation from fat tissue | |||
* Alternative to animal models and the MTT Assay | |||
==Contact Information== | |||
Email: profeliza.64@gmail.com | |||
==External Links== | ==External Links== | ||
Latest revision as of 13:13, 10 August 2026
Eliza Chakraborty is an Indian professor of biotechnology and biomedical scientist known for her extensive research in stem cell technology, biomaterials, tissue engineering, and cancer stem cell targeted drug discovery. She has 27 years of experience, including 10 years in the USA, and has contributed significantly to biomedical sciences. She served as Professor of Biotechnology and Head of the DST-FIST Center at Meerut Institute of Engineering and Technology (MIET), Meerut, Uttar Pradesh, from 2014 to 2025, and is currently self-employed.
Education
Eliza Chakraborty completed her PhD at the Central Drug Research Institute (CDRI) in Lucknow, India. She also pursued postdoctoral research in both the USA and India, gaining international experience in biomedical sciences.
Career
Eliza Chakraborty has served as faculty at the Geffen School of Medicine, University of California, Los Angeles (UCLA). She was the Head of the DST-FIST Centre from 2019 to 2024 and has been a professor of biotechnology from 2013 to 2025, with 27 years of overall professional experience, including 10 years in the USA. From 2014 to 2025, she served as Professor of Biotechnology and Head of Department (HOD), DST-FIST Center, at Meerut Institute of Engineering and Technology (MIET), Meerut, Uttar Pradesh, and was the founder and head of the DST-FIST Centre, Medical Translational Biotechnology Lab, and Stem cell & cancer cell culture lab there. She is currently self-employed.
She introduced Stemformatic in India in 2016 at the Science Congress. She also pioneered the introduction of Biosafety Level 2 laboratories in semi-urban areas of India. Her research areas include stem cell technology, biomaterials and tissue engineering, cancer stem cell targeted drug discovery, alternative native animal model development, and infectious diseases. Her infectious disease research has been sponsored by WHO, ICMR India, and NIH USA.
Eliza Chakraborty has overseen outcomes-based student projects and provided senior student mentorship.
She holds four granted patents and has eight patents pending.
She is a life member of the Indian Science Congress and the Indian Academy of Biomedical Science (IABS). She served as an executive board member of IABS from 2019 to 2024 and was a national advisory board member of IABS from 2020 to 2022.
Her first review article, on hydrogel-based tissue engineering, has surpassed 100 citations. The article was written in collaboration with her student and later research collaborator, Shikha, and focused on biomaterials, a widely relevant subject in the field, at a time when Shikha was transitioning her career toward an M.Tech.
For more than five years, Eliza Chakraborty has served as a Biosafety Resource Person, including for DBT Star College, and has trained more than 1,000 young aspirants in Biosecurity (Biosafety and Lab Safety).
Achievements
Eliza Chakraborty is a recipient of national awards recognizing her contributions to biotechnology and biomedical sciences, including:
- Best Educationist Award (Certificate of Excellence) – conferred by the KTK Outstanding Achievers and Education Foundation on 18 September 2022, in New Delhi, in recognition of her outstanding achievements and contribution in the field of Biomedical Sciences, signed by Major Yashpal Singh (Retd.), Chairman, KTK Outstanding Achievers and Education Foundation.
- Bharat Gaurav Puraskar – conferred by the KTK Outstanding Achievers and Education Foundation on 24 July 2022, in New Delhi, in recognition of her outstanding achievements and contribution in the field of Biomedical Sciences.
- Author of "Hydrogel based tissue engineering and its future applications in personalized disease modeling and regenerative therapy," published in the Beni-Suef University Journal of Basic and Applied Sciences (Springer Nature), which has surpassed 100 citations.
- Overseen outcomes-based student projects
- Holds 4 granted patents, with 8 patents pending
- Author of a recent research paper that has received 110 citations, published in a Scientific journal with an impact factor above 20
- Trained more than 1,000 young aspirants in Biosecurity (Biosafety and Lab Safety)
- Served for more than 5 years as a Biosafety Resource Person, including for DBT Star College
Technology Transfer Readiness
Eliza Chakraborty has indicated readiness for technology transfer on the following developments:
- Cost-effective Biomaterials for 3D cell culture and Bioink
- Early and stage-dependent biomarker-based prostate cancer detection product, ready to launch
- Cost-effective stem cell isolation from fat tissue
- Alternative to animal models and the MTT Assay
Contact Information
Email: profeliza.64@gmail.com